Cutting-Edge Nanocarrier-Based Strategies in the Management of Leukaemia
- 1st Edition - May 1, 2026
- Latest edition
- Editors: Devesh U. Kapoor, Bhupendra G. Prajapati, Anand Krishnan
- Language: English
Cutting-edge Nanocarrier-based Strategies in the Management of Leukaemia addresses the growing importance of nanocarriers in leukaemia treatment. It explores advancements in… Read more
Purchase options
Cutting-edge Nanocarrier-based Strategies in the Management of Leukaemia addresses the growing importance of nanocarriers in leukaemia treatment. It explores advancements in nanotechnology, highlighting therapies like siRNA, miRNA, and gene therapy that improve patient outcomes. This book fills a critical gap in current literature, serving as a valuable resource for researchers, clinicians, and students. This book begins with an introduction to leukemia, covering its epidemiology and risk factors. It then delves into innovative therapies and the use of various nanocarriers such as polymeric nanoparticles, liposomes, dendrimers, and hydrogels. Additionally, it discusses precision medicine, AI in leukaemia care, and strategies to overcome treatment resistance, enriched with tables, figures, and images. Healthcare providers, including physicians, immunologists, oncologists, and pharmacists, will find this book invaluable. It educates on cutting-edge therapies and offers practical insights into personalized patient care, making it essential for those involved in leukaemia management.
- Provides an in-depth exploration of various nanocarrier-based therapies for leukemia
- Integrates perspectives from multiple fields, such as nanotechnology, artificial intelligence, and personalized medicine, making it a valuable resource for a diverse audience including researchers, clinicians, and healthcare providers
- Enhances comprehension and provides practical insights, helping readers to better understand and apply the discussed therapies in clinical settings
Researchers, clinicians, and healthcare providers specializing in oncology, hematology, nanotechnology, and personalized medicine.
1. Introduction
2. siRNA and miRNA therapies for leukaemia
3. Gene therapy for leukaemia
4. Exploring Polymeric nanoparticles in leukaemia management
5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions
6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy
7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress
8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery
9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications
10. Advances in Leukemia Treatment using Micelles and Dendrimers
11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy
12. Biological and immunological aspects of nanocarriers and nano-vaccines
13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer
2. siRNA and miRNA therapies for leukaemia
3. Gene therapy for leukaemia
4. Exploring Polymeric nanoparticles in leukaemia management
5. Magnetic Nanoparticles in Leukemia Therapy: Advancements and Future Directions
6. Mesoporous Silica Nanoparticles: A Novel Approach in Targeted Leukemia Therapy
7. Targeted Leukemia Therapy with Solid Lipid Nanoparticles: Potential and Progress
8. The Role of Exosomes in Leukemia Treatment: Advancements in Biomarker Discovery and Drug Delivery
9. Nanoemulsion-Based Drug Delivery in Leukemia: Potential and Progress in Therapeutic Applications
10. Advances in Leukemia Treatment using Micelles and Dendrimers
11. Revolutionizing Leukemia Therapy with Liposomes and Niosomes: Targeted Delivery and Improved Efficacy
12. Biological and immunological aspects of nanocarriers and nano-vaccines
13. Leveraging AI and machine learning for prostate cancer management 14. Role of DNA Origami and mRNA/siRNA nanocarriers in prostate cancer
- Edition: 1
- Latest edition
- Published: May 1, 2026
- Language: English
DK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, where he has served since September 2010. He holds a B.Pharm from the University of Rajasthan and an M.Pharm in Pharmaceutics from Rajasthan University of Health Sciences, along with a PhD in pharmaceutical sciences. With 14 years of teaching and administrative experience, Dr. Kapoor has authored over 35 research and review articles in esteemed national and international journals and contributed to several books published by Elsevier, Bentham Science, MDPI, Springer, and Wiley. His research focuses on osmotic drug delivery systems, solid lipid nanoparticles, and microspheres. He has received significant grants for organizing national seminars and faculty development programs. Dr. Kapoor holds three design patents and has delivered over 10 expert talks at various national conferences. He is currently the editor of three international books with prominent publishers.
Affiliations and expertise
Professor, Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, IndiaBP
Bhupendra G. Prajapati
Dr. Bhupendra Gopalbhai Prajapati is a Professor (Research Cadre) at Parul Institute of Pharmacy, Parul University, Gujarat, India. He is also acting as Adjunct Professor at Department of Industrial Pharmacy, Faculty of Pharmacy, Silpakorn University, Thailand. With over 22 years of experience in academia, research, and industry, he specializes in lipid-based formulations, nano/microparticulate drug delivery, and bioavailability enhancement. A recipient of several prestigious awards including the AICTE Young Teacher Award and Ganpat University's Staff Excellence honors, Dr. Prajapati has published over 350 research/review papers, and has contributed to more than 170 book chapters. He actively mentors Ph.D. and PG scholars and serves as editor or section editor for several international publications in pharmaceutical sciences.
Affiliations and expertise
Parul Institute of Pharmacy, Faculty of Pharmacy, Parul University, Waghodia, Vadodara, Gujarat, IndiaAK
Anand Krishnan
Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.
Affiliations and expertise
Precision Medicine and Integrated Nano-Diagnostics (P-MIND) Research Group, Office of the Dean, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa